Mitiglinide
![(12) United States Patent (10) Patent N0.: US 7,888,382 B2 Kiyono Et A]](http://data.docslib.org/img/264x/31b89403a4aa15aca0cd085d3ef68a3b.webp)
Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Differential Interactions of Nateglinide and Repaglinide on the Human -Cell Sulphonylurea Receptor 1
- Drug Interactions of Sglt2 Inhibitors (Gliflozins) Involving Ugt Enzymes Dr
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Perturbation of Mitiglinide Metabolism by Chronic Unpredicted Mild Stress
- Pregabalin Lercanidipine Hydrochloride Ulipristal Acetate
- Research Article NOVEL DRUG DISCOVERY for DIABETES TYPE
- The Proinsulin/Insulin
- (12) Patent Application Publication (10) Pub. No.: US 2009/0311321 A1 Mimura Et Al
- Tresiba, INN-Insulin Degludec
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Drug Composition for Prevention Or Inhibition of Advance of Diabetic Complication
- WO 2U11/132171 Al
- Efficacy and Safety of Mitiglinide in Diabetic Patients on Maintenance Hemodialysis
- Nateglinide and Mitiglinide, but Not Sulfonylureas, Induce Insulin Secretion Through a Mechanism Mediated by Calcium
- Pharmacology
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Standouts Melanoma Drug Yervoy, with Seemingly Better Tolerability